Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Doi

Showing results (361-370 of 494) with videos related to

Pageof 50
Sort By:
Antimicrobial Agents and Chemotherapy|April 5, 2017
Structural Modification of Lipopolysaccharide Conferred by <i>mcr-1</i> in Gram-Negative ESKAPE PathogensYi-Yun Liu, Courtney E Chandler, Lisa M Leung, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2008
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in BrazilDoroti de Oliveira Garcia, Yohei Doi, Dora Szabo, et al.
Journal of Global Antimicrobial Resistance|February 21, 2025
Phenotypic and in silico characterization of carbapenem-resistant Serratia marcescens clinical strainsAnelise Stella Ballaben, Otávio G G de Almeida, Joseane Cristina Ferreira, et al.
ESC Heart Failure|September 23, 2021
Variability in estimated glomerular filtration rate and patients' outcomes in a real-world heart failure populationTatsufumi Oka, Takayuki Hamano, Tomohito Ohtani, et al.
Journal of Clinical Microbiology|June 20, 2020
Clinical and Genomic Epidemiology of Carbapenem-Nonsusceptible <i>Citrobacter</i> spp. at a Tertiary Health Care Center over 2 DecadesAhmed Babiker, Daniel R Evans, Marissa P Griffith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 19, 2019
Early Experience With Meropenem-Vaborbactam for Treatment of Carbapenem-resistant Enterobacteriaceae InfectionsRyan K Shields, Erin K McCreary, Rachel V Marini, et al.
The Journal of Antimicrobial Chemotherapy|March 4, 2023
Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patientsEmily L Heil, Kimberly C Claeys, Ellen G Kline, et al.
Microbiology Spectrum|February 10, 2026
Diagnostic utility of quantitative interferon-gamma release assays in elderly patients with tuberculosisYoshikazu Mutoh, Yusuke Minato, Yuya Kawamoto, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2019
Small-Molecule Inhibitor of FosA Expands Fosfomycin Activity to Multidrug-Resistant Gram-Negative PathogensAdam D Tomich, Erik H Klontz, Daniel Deredge, et al.
The Journal of Antibiotics|December 17, 2015
Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumanniiThien B Tran, Soon-Ee Cheah, Heidi H Yu, et al.
Pageof 50

Showing results (361-370 of 494) with videos related to

Sort By:
Pageof 50
Antimicrobial Agents and Chemotherapy|April 5, 2017
Structural Modification of Lipopolysaccharide Conferred by <i>mcr-1</i> in Gram-Negative ESKAPE PathogensYi-Yun Liu, Courtney E Chandler, Lisa M Leung, et al.
Antimicrobial Agents and Chemotherapy|March 19, 2008
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in BrazilDoroti de Oliveira Garcia, Yohei Doi, Dora Szabo, et al.
Journal of Global Antimicrobial Resistance|February 21, 2025
Phenotypic and in silico characterization of carbapenem-resistant Serratia marcescens clinical strainsAnelise Stella Ballaben, Otávio G G de Almeida, Joseane Cristina Ferreira, et al.
ESC Heart Failure|September 23, 2021
Variability in estimated glomerular filtration rate and patients' outcomes in a real-world heart failure populationTatsufumi Oka, Takayuki Hamano, Tomohito Ohtani, et al.
Journal of Clinical Microbiology|June 20, 2020
Clinical and Genomic Epidemiology of Carbapenem-Nonsusceptible <i>Citrobacter</i> spp. at a Tertiary Health Care Center over 2 DecadesAhmed Babiker, Daniel R Evans, Marissa P Griffith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 19, 2019
Early Experience With Meropenem-Vaborbactam for Treatment of Carbapenem-resistant Enterobacteriaceae InfectionsRyan K Shields, Erin K McCreary, Rachel V Marini, et al.
The Journal of Antimicrobial Chemotherapy|March 4, 2023
Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patientsEmily L Heil, Kimberly C Claeys, Ellen G Kline, et al.
Microbiology Spectrum|February 10, 2026
Diagnostic utility of quantitative interferon-gamma release assays in elderly patients with tuberculosisYoshikazu Mutoh, Yusuke Minato, Yuya Kawamoto, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2019
Small-Molecule Inhibitor of FosA Expands Fosfomycin Activity to Multidrug-Resistant Gram-Negative PathogensAdam D Tomich, Erik H Klontz, Daniel Deredge, et al.
The Journal of Antibiotics|December 17, 2015
Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumanniiThien B Tran, Soon-Ee Cheah, Heidi H Yu, et al.
Pageof 50